
Overview
Bartosz Walczyszyn is a Hematologist and an Oncologist in Mooresville, North Carolina. Dr. Walczyszyn has been practicing medicine for over 15 years is highly rated in 7 conditions, according to our data. His top areas of expertise are Carcinoid Syndrome, Pleuropulmonary Blastoma, Neuroendocrine Tumor, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
171 Fairview Rd, Mooresville, NC 28117
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Atrium Health Levine Cancer Institute
Ruben Mesa is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Mesa is highly rated in 18 conditions, according to our data. His top areas of expertise are Myelofibrosis, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Bone Marrow Transplant, and Splenectomy. Dr. Mesa is currently accepting new patients.
Atrium Health Levine Cancer Institute (Hematology)
Manisha Bhutani is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Bhutani is highly rated in 11 conditions, according to our data. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is currently accepting new patients.
Office
Ifeyinwa Osunkwo is a Hematologist and an Oncologist in Charlotte, North Carolina. Dr. Osunkwo is highly rated in 7 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.
Frequently Asked Questions about Dr. Bartosz Walczyszyn
How do I make an appointment with Dr. Bartosz Walczyszyn?
You can book an appointment with Dr. Bartosz Walczyszyn by calling their office at 704-660-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Bartosz Walczyszyn a top-rated expert for Carcinoid Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bartosz Walczyszyn is classified as an Advanced expert for Carcinoid Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Bartosz Walczyszyn specialize in?
While Dr. Bartosz Walczyszyn is a Oncology, they have specific expertise in Carcinoid Syndrome, Pleuropulmonary Blastoma, and Neuroendocrine Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Bartosz Walczyszyn participate in research or clinical trials?
Yes. Dr. Bartosz Walczyszyn has published 1 articles and abstracts on conditions like Carcinoid Syndrome. You can view a list of Dr. Bartosz Walczyszyn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Bartosz Walczyszyn accept my insurance?
Dr. Bartosz Walczyszyn accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 704-660-4000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Walczyszyn isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Carcinoid SyndromeDr. Walczyszyn isAdvanced. Learn about Carcinoid Syndrome.
- Childhood Acute Myeloid LeukemiaDr. Walczyszyn isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Neuroendocrine TumorDr. Walczyszyn isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Acute Mountain SicknessDr. Walczyszyn isExperienced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Walczyszyn isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Walczyszyn isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Walczyszyn isExperienced. Learn about Anal Cancer.
- AnemiaDr. Walczyszyn isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Walczyszyn isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.


